Sibutramine Hydrochloride Hydrate/Metformin Hydrochloride

盐酸西布曲明水合物/盐酸二甲双胍

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSibutramine Hydrochloride Hydrate/Metformin Hydrochloride
Drug Alias Name盐酸二甲双胍/盐酸西布曲明水合物sibutramine + metforminMetformin/SibutramineMetformin Hydrochloride/Sibutramine Hydrochloride Hydratesibutramine/metformin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitorsDopamine transporter antagonists +[4] 
TargetsNorepinephrine transporterDopamine transporterProtein kinase AMP-activated non-catalytic subunit beta 1 +[4] 
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsYes Metformin HydrochlorideSibutramine Hydrochloride Hydrate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSilanes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Silanes Sa De Cv
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A